About

Dr. Ritu Salani is a leading gynecologic oncologist whose research has transformed the surgical management of endometrial cancer, particularly through the advancement of robotic surgery. Her work focuses on optimizing perioperative outcomes, reducing hospital readmissions, and improving quality of life for patients, including high-risk populations such as the elderly and those with obesity. Dr. Salani’s landmark prospective trial (76 citations) validated the use of robotic sentinel lymph node assessment with indocyanine green, a technique that has become a standard of care for staging endometrial cancer. She has also pioneered efforts to reduce readmissions after robotic hysterectomy (26 citations) and to enhance postoperative recovery (20 citations). Beyond clinical innovation, Dr. Salani is a dedicated educator, having developed and validated robotic surgery training curricula and simulators (35, 10, and 4 citations) to train the next generation of surgeons. Her work has been cited over 200 times, reflecting her profound impact on both surgical practice and patient-centered care in gynecologic oncology.

Research Focus

Key Achievements

8
H-Index
10
Papers
238
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739)
76 citations · 2019
📈 Most Prolific Year: 2015 (3 Papers)
🤝 Key Collaborators: 46
🏛 Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, The Ohio State University Wexner Medical Center, University of California, Los Angeles

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago